Search Within

Isabelle C Riviere

  1. "2018"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (7)
Groups
  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (15)
  4. GSK Faculty (15)
  5. Hematologic Malignancies Research (15)
  6. Adult Leukemia (12)

More Groups

People
  1. Renier Brentjens (12)
  2. Michel Sadelain (11)
  3. Brigitte Senechal (9)
  4. Xiuyan Wang (9)
  5. Jae Park (8)
  6. Elizabeth Halton (7)

More People

Years
  1. 2018 (18)
Publications
  1. Molecular Therapy (6)
  2. Blood (5)
  3. Cancer Discovery (1)
  4. Cancer Research (1)
  5. Hematology/Oncology Clinics of North America (1)
  6. Leukemia and Lymphoma (1)

More Publications

Publishers
  1. Nature Publishing Group (7)
  2. American Society of Hematology (5)
  3. American Association for Cancer Research (2)
  4. Elsevier Inc. (1)
  5. Lippincott Williams & Wilkins (1)
  6. Massachusetts Medical Society (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Generation of off-the-shelf TCR-less CAR-targeted cytotoxic T cells from renewable pluripotent cells for cancer immunotherapy
    Meeting Abstract

    Clarke, R. L.; van der Stegen, S.; Lee, T.; Mansilla-Soto, J.; Chang, C. W.; Sasaki, J.; Husain, M.; Peralta, E.; Hardy, I.; Ortiz, E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • CAR T cell therapy targeting G protein-coupled receptor class C group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma
    Meeting Abstract

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T.; Ghoddusi, M.; Purdon, T. J.; Do, T.; Wang, X.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Batlevi, C. L.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R. R.; Bernal, Y.; Hall, M.; Pineda, J.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Pluripotent cell-derived off-the-shelf TCR-less CAR-targeted cytotoxic T cell therapeutic for the allogeneic treatment of B cell malignancies
    Meeting Abstract

    Clarke, R.; Van Der Stegen, S.; Chang, C. W.; Husain, M.; Lai, Y. S.; Peralta, E.; Stokely, L.; Abujarour, R.; Dinella, J.; Lee, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Neurotoxicity associated with CD19-specific chimeric antigen receptor T cell therapy for adult acute lymphoblastic leukemia (B-ALL)
    Meeting Abstract

    Santomasso, B.; Park, J. H.; Riviere, I.; Mead, E.; Li, D.; Senechal, B.; Purdon, T.; Halton, E.; Diamonte, C.; Sadelain, M.; more...
    Neurology (2018)

    Fulltext@MSK | Save
  • Screening clinical cell products for replication competent retrovirus: The National Gene Vector Biorepository experience
    Journal Article

    Cornetta, K.; Duffy, L.; Feldman, S. A.; Mackall, C. L.; Davila, M. L.; Curran, K. J.; Junghans, R. P.; Tang, J. Y.; Kochenderfer, J. N.; O'Cearbhaill, R.; more...
    Molecular Therapy - Methods & Clinical Development (2018)

    Fulltext@MSK | Save
  • Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia
    Journal Article

    Santomasso, B. D.; Park, J. H.; Salloum, D.; Riviere, I.; Flynn, J.; Mead, E.; Halton, E.; Wang, X.; Senechal, B.; Purdon, T.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save